H
Hsieh-Chih Tsai
Researcher at National Taiwan University of Science and Technology
Publications - 153
Citations - 3245
Hsieh-Chih Tsai is an academic researcher from National Taiwan University of Science and Technology. The author has contributed to research in topics: Chemistry & Drug delivery. The author has an hindex of 25, co-authored 131 publications receiving 2164 citations. Previous affiliations of Hsieh-Chih Tsai include Chung Yuan Christian University & Taipei Medical University.
Papers
More filters
Journal ArticleDOI
Polysaccharide based nanogels in the drug delivery system: Application as the carrier of pharmaceutical agents
TL;DR: Chemistry of certain common polysaccharides, several methodologies used to synthesizepolysaccharide nanoparticles, and primarily focused on the poly Saccharide (or polySaccharide derivative) based nanogels as the carrier of pharmaceutical agents are described.
Journal ArticleDOI
Drug Carrier for Photodynamic Cancer Therapy
TL;DR: Several organic and inorganic PS carriers that have been studied to enhance the efficacy of photodynamic therapy against cancer are summarized.
Journal ArticleDOI
Graft and diblock copolymer multifunctional micelles for cancer chemotherapy and imaging.
Hsieh-Chih Tsai,Wei Hsiang Chang,Chun Liang Lo,Cheng Hung Tsai,Che Hau Chang,Ta Wei Ou,Tzu Chen Yen,Ging-Ho Hsiue +7 more
TL;DR: In vivo study revealed that specific targeting of folate-micelles exhibited cancer targeting and efficiency expression on tumor growth, indicating that multifunctional micelles prepared from poly(HEA-co-histidine)-g-PLA and folate -PEG-PLA have great potential in cancer chemotherapy and diagnosis.
Journal ArticleDOI
Poly(N-isopropylacrylamide) hydrogels with interpenetrating multiwalled carbon nanotubes for cell sheet engineering
TL;DR: A simple method is reported that provides sufficient mechanical strength to PNIPAAM hydrogels so that anchorage-dependent cells can be cultivated and provides a superior system for preparing cell sheets.
Journal ArticleDOI
Dose escalation intensity-modulated radiotherapy–based concurrent chemoradiotherapy is effective for advanced-stage thoracic esophageal squamous cell carcinoma
Chia Lun Chang,Hsieh-Chih Tsai,Wei Cheng Lin,Jer Hwa Chang,Han Lin Hsu,Jyh Ming Chow,Kevin Sheng Po Yuan,Alexander T.H. Wu,Szu Yuan Wu +8 more
TL;DR: Low-dose IMRT-based CCRT yields more favorable survival outcomes in patients with advanced-stage TESCC, compared with standard- dose IM RT-basedCCRT, which yields more unfavorable survival outcomes, Multivariate Cox regression analysis indicated.